Skip to main content

Advertisement

Log in

Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

The validity of our proposed lobe-specific regional lymph node stations (LSRLNS) was evaluated as a method for navigation during lymphadenectomy in patients with early stage non-small cell lung cancer (NSCLC).

Methods

A total of 725 NSCLC patients with c-T2N1M0 or less extensive disease who had undergone a curative operation with complete mediastinal lymph node dissection (MLND) were studied. The LSRLNS were #2, #3, #4 and #10 for the right upper lobe, #11i, #11s, #7 and #8 for the right lower lobe, #4, #5 and #6 for the left superior division, #11, #5 and #7 for the left lingular division and #11, #7 and #8 for the left lower lobe.

Results

If the LSRLNS were used for pathological examinations during surgery, 599 p-N0 and 39 p-N1 patients diagnosed with no metastasis would have been subjected to a selective MLND, while 20 p-N1 and 65 p-N2 patients who had a diagnosis of metastasis would have been navigated to a complete MLND. Two p-N2 patients with a diagnosis of no metastasis would have inappropriately undergone a selective MLND, resulting in the false negative rate at 0.3 %.

Conclusion

Intra-operative pathological examination using our LSRLNS may accurately reveal the status of metastasis, and appropriately lead to a selective or complete MLND in patients with c-T2N1M0 or less extensive disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Martini N, Flehinger BJ, Zaman MB, Beattie EJ. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg. 1983;198:386–97.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Naruke T, Goya T, Tsuchiya R, Suemasu K. The importance of surgery to non-small cell carcinoma of the lung with mediastinal lymph node metastasis. Ann Thorac Surg. 1988;96:440–7.

    CAS  Google Scholar 

  3. Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest. 1991;100:422–8.

    Article  PubMed  CAS  Google Scholar 

  4. Funatsu T, Matsubara Y, Hatakenaka R, Kosaba S, Yasuda Y, Ikeda S. The role of mediastinoscopic biopsy in preoperative assessment of lung cancer. J Thorac Cardiovasc Surg. 1992;104:1688–95.

    PubMed  CAS  Google Scholar 

  5. Miyoshi S, Maebeya S, Suzuma T, et al. Which mediastinal lymph nodes should be examined during operation for diagnosing N0 or N1 disease in bronchogenic carcinoma? Haigan. 1997;37:475–84.

    Article  Google Scholar 

  6. Yoshimasu T, Miyoshi S, Oura S, et al. Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations. J Thorac Cardiovasc Surg. 2005;130:433–7.

    Article  PubMed  Google Scholar 

  7. Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer. Results of a prospective randomized trial. Ann Surg. 1998;227:138–44.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 trial. J Thorac Cardiovasc Surg. 2011;141:662–70.

    Article  PubMed  Google Scholar 

  9. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg. 1996;111:1125–34.

    Article  PubMed  CAS  Google Scholar 

  10. Okada M, Tsubota N, Yoshimura Y, Miyamoto Y. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg. 1998;116:949–53.

    Article  PubMed  CAS  Google Scholar 

  11. Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 2006;81:1028–32.

    Article  PubMed  Google Scholar 

  12. Ishiguro F, Matsuo K, Fukai T, Mori S, Hatooka S, Mitsudomi T. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score. J Thorac Cardiovasc Surg. 2010;139:1001–6.

    Article  PubMed  Google Scholar 

  13. Sobin LH, Wittekind C. TNM classification of malignant tumors. 6th ed. New York: Wiley; 2002.

    Google Scholar 

  14. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg. 1978;76:832–9.

    PubMed  CAS  Google Scholar 

  15. The Japan Lung Cancer Society. General rule for clinical and pathological record of lung cancer. Tokyo: Kanehara; 1995. p. 83.

    Google Scholar 

  16. Hata E. Un-vivo-Untersuchung der Lymphoszin-tigraphie: Eine neue diagnostishe Technik. In: Hamelmann H, Troidl H, editors. Behandlung des Bronchialkarziomas. Stuttgart: Thieme Verlag; 1981. p. 27.

    Google Scholar 

  17. Deslauriers J. Mediastinal lymph nodes: ignore? Sample? Dissect? The role of mediastinal dissection in the surgical management of primary lung cancer. Gen Thorac Cardiovasc Surg. 2012;60:724–34.

    Article  PubMed  Google Scholar 

  18. Toyooka S, Kiura K, Shien K, Katsui K, Hotta K, Kanazawa S, et al. Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis. Interact Cardiovasc Thorac Surg. 2012;15:954–60.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Shien K, Toyooka S, Kiura K, Matsuo K, Soh J, Yamane M, et al. Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer. Ann Surg Oncol. 2012;19:2685–92.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Oda M, Watanabe Y, Shimizu J, Murakami S, Ohta Y, Sekido N, et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer. 1998;22:23–30.

    Article  PubMed  CAS  Google Scholar 

  21. Shimizu K, Yoshida J, Nagai K, Nishimura M, Ishii G, Morishita Y, et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;130:160–5.

    Article  PubMed  Google Scholar 

  22. Manac’h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg. 2001;71:1088–93.

    Article  PubMed  Google Scholar 

  23. Okiemy G, Foucault C, Avisse C, Hidden G, Riquet M. Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes. Surg Radiol Anat. 2003;25:32–5.

    Article  PubMed  CAS  Google Scholar 

  24. Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg. 2005;79:225–33.

    Article  PubMed  Google Scholar 

  25. Shimizu K, Morishita Y, Yoshida J, Nagai K. Mediastinal lymph node metastases and visceral pleural invasion in non-small cell lung cancer patients. Ann Thorac Surg. 2006;81:1947–8.

    Article  PubMed  Google Scholar 

  26. Imai K, Minamiya Y, Saito H, Nakagawa T, Ito M, Ono T, et al. Detection of pleural lymph flow using indocyanine green fluorescence imaging in non-small cell lung cancer surgery: a preliminary study. Surg Today. 2013;43:249–54.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

Shinichiro Miyoshi and the co-authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinichiro Miyoshi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyoshi, S., Shien, K., Toyooka, S. et al. Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients. Surg Today 44, 2028–2036 (2014). https://doi.org/10.1007/s00595-013-0772-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-013-0772-5

Keywords

Navigation